News

To achieve these ends, the FDA will use computer modeling and artificial intelligence (AI) to predict a drug’s behavior and ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...
The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...
PETA and other animal advocacy groups have praised the Trump administration for recent announcements to phase out animal ...
Environmental Protection Agency Administrator Lee Zeldin intends to follow through with the first Trump administration‘s plan ...
The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...
The FDA announced a shift away from animal testing for drug approval, citing advanced alternatives like AI and organoids ...
The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal ...